Other serum biomarkers, such as CA-125, CEA, CA50, CA724, CA242 and AFP, also face the same limitations as those of CA 19-9 and do not have good clinical utility for the early diagnosis of PC. This evidence concerns the gene AFP and pachyonychia congenita.